Logo image of 1EXAS.MI

EXACT SCIENCES CORP (1EXAS.MI) Stock Overview

BIT:1EXAS - US30063P1057 - Common Stock

38.5 EUR
-1.2 (-3.01%)
Last: 9/1/2025, 7:00:00 PM

1EXAS.MI Key Statistics, Chart & Performance

Key Statistics
52 Week HighN/A
52 Week LowN/A
Market Cap7.29B
Shares189.32M
Float186.97M
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)-4.64
PEN/A
Fwd PE122.83
Earnings (Next)11-03 2025-11-03/amc
IPO01-30 2001-01-30
Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryBiotechnology


1EXAS.MI short term performance overview.The bars show the price performance of 1EXAS.MI in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months

1EXAS.MI long term performance overview.The bars show the price performance of 1EXAS.MI in the last 1, 2 and 3 years. 1 year 2 years 3 years

The current stock price of 1EXAS.MI is 38.5 EUR.

EXACT SCIENCES CORP / 1EXAS Daily stock chart

1EXAS.MI Competitors/Peers

The largest stocks on the EU markets in the "Biotechnology" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
4AB.DE ABBVIE INC 19.71 314.80B
1ABBV.MI ABBVIE INC 19.67 314.07B
AMG.DE AMGEN INC 13.25 132.79B
1GILD.MI GILEAD SCIENCES INC 14.85 122.10B
GIS.DE GILEAD SCIENCES INC 14.56 119.45B
VX1.DE VERTEX PHARMACEUTICALS INC 22.85 84.72B
ARGX.BR ARGENX SE 82.33 37.19B
22UA.DE BIONTECH SE-ADR N/A 20.79B
IDP.DE BIOGEN INC 8.41 16.85B
1MRNA.MI MODERNA INC N/A 8.13B
0QF.DE MODERNA INC N/A 8.09B
ABVX.PA ABIVAX SA N/A 5.22B

About 1EXAS.MI

Company Profile

1EXAS logo image EXACT Sciences Corp. is a cancer screening and diagnostics company. The company is headquartered in Madison, Wisconsin and currently employs 6,900 full-time employees. The company went IPO on 2001-01-30. The firm provides a portfolio of products for earlier cancer detection and treatment guidance. Its products and services focus on screening and precision oncology tests. The company is focusing its research and development efforts on three main areas: Colorectal Cancer Screening Test Development, MCED Test Development and MRD Test Development. Its products and services include Cologuard test, Oncotype DX Breast Recurrence Score Test, Oncotype DX Breast DCIS Score Test, Oncotype DX Colon Recurrence Score Test, OncoExTra Test, and Riskguard Test. Its flagship screening product, the Cologuard test, is a non-invasive, stool-based deoxyribonucleic acid (sDNA) screening test that utilizes a multi-target approach to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. The Oncotype DX Breast Recurrence Score test examines the activity of 21 genes in a patient’s breast tumor tissue.

Company Info

EXACT SCIENCES CORP

5505 Endeavor Lane

Madison WISCONSIN US

Employees: 6900

1EXAS Company Website

1EXAS Investor Relations

Phone: 16082845700

EXACT SCIENCES CORP / 1EXAS.MI FAQ

What is the stock price of EXACT SCIENCES CORP today?

The current stock price of 1EXAS.MI is 38.5 EUR. The price decreased by -3.01% in the last trading session.


What is the ticker symbol for EXACT SCIENCES CORP stock?

The exchange symbol of EXACT SCIENCES CORP is 1EXAS and it is listed on the Euronext Milan exchange.


On which exchange is 1EXAS.MI stock listed?

1EXAS.MI stock is listed on the Euronext Milan exchange.


What is EXACT SCIENCES CORP worth?

EXACT SCIENCES CORP (1EXAS.MI) has a market capitalization of 7.29B EUR. This makes 1EXAS.MI a Mid Cap stock.


How many employees does EXACT SCIENCES CORP have?

EXACT SCIENCES CORP (1EXAS.MI) currently has 6900 employees.


Is EXACT SCIENCES CORP (1EXAS.MI) expected to grow?

The Revenue of EXACT SCIENCES CORP (1EXAS.MI) is expected to grow by 14.7% in the next year. Check the estimates tab for more information on the 1EXAS.MI EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy EXACT SCIENCES CORP (1EXAS.MI) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does EXACT SCIENCES CORP (1EXAS.MI) stock pay dividends?

1EXAS.MI does not pay a dividend.


When does EXACT SCIENCES CORP (1EXAS.MI) report earnings?

EXACT SCIENCES CORP (1EXAS.MI) will report earnings on 2025-11-03, after the market close.


What is the Price/Earnings (PE) ratio of EXACT SCIENCES CORP (1EXAS.MI)?

EXACT SCIENCES CORP (1EXAS.MI) does not have a PE ratio as the earnings reported over the last twelve months were negative (-4.64).


1EXAS.MI Technical Analysis

ChartMill assigns a technical rating of 1 / 10 to 1EXAS.MI.


Chartmill TA Rating
Chartmill Setup Rating

1EXAS.MI Fundamental Analysis

ChartMill assigns a fundamental rating of 3 / 10 to 1EXAS.MI. The financial health of 1EXAS.MI is average, but there are quite some concerns on its profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

1EXAS.MI Financial Highlights

Over the last trailing twelve months 1EXAS.MI reported a non-GAAP Earnings per Share(EPS) of -4.64. The EPS decreased by -465.62% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -17.34%
ROE -40.71%
Debt/Equity 0.94
Chartmill High Growth Momentum
EPS Q2Q%88.89%
Sales Q2Q%15.99%
EPS 1Y (TTM)-465.62%
Revenue 1Y (TTM)12.56%

1EXAS.MI Forecast & Estimates

For the next year, analysts expect an EPS growth of 89.28% and a revenue growth 14.7% for 1EXAS.MI


Analysts
Analysts85.45
Price TargetN/A
EPS Next Y89.28%
Revenue Next Year14.7%

1EXAS.MI Ownership

Ownership
Inst Owners98.76%
Ins Owners0.87%
Short Float %N/A
Short RatioN/A